Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12172994
Pyrimidine compound as JAK kinase inhibitor
granted -
US 12171760
Use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors
granted -
US 12171765
Combination therapies using PRMT5 inhibitors for the treatment of cancer
granted -
US 12168023
Inhibitors of adenosine 5′-nucleotidase
granted -
US 12162877
Human dihydroorotate dehydrogenase (hDHODH) inhibitors and their use in targeting oncological diseases sensitive to pyrimidine starvation
granted -
US 12162838
Human plasma kallikrein inhibitors
granted -
US 12161618
Methods of identifying and treating patients with HIF-2 inhibitor resistance
granted -
US 12162818
Inhibitors of the n-terminal domain of the androgen receptor
granted -
US 12157891
Treatment of uveitis with endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibitors
granted -
US 12156879
Combining BACE1 inhibitors with mGluR agonists for Alzheimer's disease therapy
granted -
US 12156880
Heterocyclic RIP1 kinase inhibitors
granted -
US 2024390332
Combination treatment and/or prevention of renal diseases and/or hypertension in non-human mammals comprising one or more SGLT-2 inhibitors and telmisartan
granted -
US 2024390317
COMBINATION TREATMENT AND/OR PREVENTION OF CARDIAC DISEASES IN NON-HUMAN MAMMALS COMPRISING ONE OR MORE SGLT-2 INHIBITORS AND PIMOBENDAN AND/OR TELMISARTAN
granted -
US 12152034
FGFR inhibitors and methods of making and using the same
granted -
US 12145925
Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer
granted -
US 12144813
PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer
granted -
US 12145944
Imidazopyrimidines as EED inhibitors and the use thereof
granted -
US 12138263
Pyrazolo[3,4-b]pyrazine SHP2 phosphatase inhibitors and methods of use thereof
granted -
US 12133849
Method for treating cancer using a BCL-2 inhibitor in conjunction with an alpha- emitting radioimmunotherapeutic
granted -
US 12128015
APE/REF1 inhibitors for the treatment of cancer
granted -
US 12129262
CDK inhibitors and their use as pharmaceuticals
granted -
US 12128048
Combination therapies using PRMT5 inhibitors for the treatment of cancer
granted -
US 12129263
Kinase inhibitors and uses thereof
granted -
US 12122773
Crystalline hydrate of a JAK inhibitor compound
granted